| Intratumor heterogeneity in early lung adenocarcinoma MF Senosain, PP Massion Frontiers in oncology 10, 349, 2020 | 51 | 2020 |
| Genomic Underpinnings of Tumor Behavior in In Situ and Early Lung Adenocarcinoma J Qian, S Zhao, Y Zou, SMJ Rahman, MF Senosain, T Stricker, H Chen, ... American Journal of Respiratory and Critical Care Medicine 201 (6), 697-706, 2020 | 51 | 2020 |
| HLA-DR cancer cells expression correlates with T cell infiltration and is enriched in lung adenocarcinoma with indolent behavior MF Senosain, Y Zou, T Novitskaya, G Vasiukov, AB Balar, DJ Rowe, ... Scientific Reports 11 (1), 14424, 2021 | 24 | 2021 |
| Tumoral densities of T-cells and mast cells are associated with recurrence in early-stage lung adenocarcinoma MN Kammer, H Mori, DJ Rowe, SC Chen, G Vasiukov, T Atwater, ... JTO Clinical and Research Reports 4 (9), 100504, 2023 | 5 | 2023 |
| Integrated cells and collagen fibers spatial image analysis G Vasiukov, T Novitskaya, MF Senosain, A Camai, A Menshikh, ... Frontiers in bioinformatics 1, 758775, 2021 | 4 | 2021 |
| Cancer testis antigen burden (CTAB): a novel biomarker of tumor-associated antigens in lung cancer RJ Seager, MF Senosain, E Van Roey, S Gao, P DePietro, MK Nesline, ... Journal of Translational Medicine 22 (1), 141, 2024 | 3 | 2024 |
| Cancer-associated fibroblasts in early-stage lung adenocarcinoma correlate with tumor aggressiveness G Vasiukov, Y Zou, MF Senosain, JSM Rahman, S Antic, KM Young, ... Scientific Reports 13 (1), 17604, 2023 | 3 | 2023 |
| Immunologic Factors Associated with Differential Response to Neoadjuvant Chemoimmunotherapy in Triple-Negative Breast Cancer RJ Seager, H Ko, S Pabla, MF Senosain, P Kalinski, E Van Roey, S Gao, ... Journal of Personalized Medicine 14 (5), 481, 2024 | 2 | 2024 |
| Integrated multi-omics analysis of early lung adenocarcinoma links tumor biological features with predicted indolence or aggressiveness MF Senosain, Y Zou, K Patel, S Zhao, A Coullomb, DJ Rowe, JM Lehman, ... Cancer Research Communications 3 (7), 1350-1365, 2023 | 2 | 2023 |
| Comprehensive Assessment of Immune Phenotype and Its Effects on Survival Outcomes in HER2-Low versus HER2-Zero Breast Cancer HC Ko, RJ Seager, S Pabla, MF Senosain, E Van Roey, S Gao, ... Breast Cancer: Targets and Therapy, 483-495, 2024 | 1 | 2024 |
| LAG3 landscape in solid tumors and its association with immunotherapy outcomes in non-small cell lung cancer. R Seager, MF Senosain, E Van Roey, S Gao, P DePietro, MK Nesline, ... Journal of Clinical Oncology 41 (16_suppl), e21113-e21113, 2023 | 1 | 2023 |
| Interaction between VEGF-A and immune checkpoint targets in triple-negative breast cancer and mechanisms of immune evasion and tumor progression. RJ Seager, S Pabla, S Gandhi, MF Senosain, H Parikh, E Van Roey, ... Journal of Clinical Oncology 42 (16_suppl), 1096-1096, 2024 | | 2024 |
| Comprehensive genomic and immune profiling of non-V600 BRAF-mutated melanomas: Implications for therapeutic strategies beyond BRAF/MEK inhibitors. MF Senosain, S Pabla, RJ Seager, E Van Roey, S Gao, H Parikh, ... Journal of Clinical Oncology 42 (16_suppl), e21544-e21544, 2024 | | 2024 |
| Novel HLA-Ilo/HLA-IIhi phenotype and immune evasion in triple-negative breast cancer. HC Ko, RJ Seager, S Gandhi, MF Senosain, H Parikh, E Van Roey, S Gao, ... Journal of Clinical Oncology 42 (16_suppl), 1095-1095, 2024 | | 2024 |
| Pervasive loss of antigen presentation in solid tumors driven by loss of HLA class I expression. S Pabla, HC Ko, MF Senosain, H Parikh, RJ Seager, E Van Roey, S Gao, ... Journal of Clinical Oncology 42 (16_suppl), e14654-e14654, 2024 | | 2024 |
| Abstract PO5-06-09: Metastatic triple negative breast cancer has distinct tumor immune landscape R Seager, H Ko, S Pabla, MF Senosain, E Van Roey, S Gao, K Strickland, ... Cancer Research 84 (9_Supplement), PO5-06-09-PO5-06-09, 2024 | | 2024 |
| Abstract PO4-25-03: Comprehensive immune profiling reveals factors associated with neoadjuvant chemotherapy response in triple negative breast cancer R Seager, H Ko, S Pabla, MF Senosain, P Kalinski, E Van Roey, S Gao, ... Cancer Research 84 (9_Supplement), PO4-25-03-PO4-25-03, 2024 | | 2024 |
| Landscape of TIGIT and PD-L1 co-expression in solid tumors S Pabla, MF Senosain, RJ Seager, H Parikh, E Van Roey, S Gao, ... Cancer Research 84 (6_Supplement), 7526-7526, 2024 | | 2024 |
| Landscape of HIF-1α expression across 24,186 solid tumors using comprehensive immune profiling HI Parikh, S Pabla, MF Senosain, R Seager, E Vanroey, S Gao, ... Cancer Research 84 (6_Supplement), 379-379, 2024 | | 2024 |
| 175 Metastatic triple negative breast cancer has distinct tumor immune landscape R Seager, H Ko, S Pabla, MF Senosain, E Van Roey, S Gao, ... Journal for ImmunoTherapy of Cancer 11 (Suppl 1), 2023 | | 2023 |
